A Study of the Relationship Between Cystatin C and Metabolic Bone Disease in Preterm Infants | Zendy

Sabriye Korkut | Zendy; Şeyma Memur | Zendy; Hülya Halis | Zendy; Osman Baştuğ | Zendy; Levent Korkmaz | Zendy; Ahmet Özdemir | Zendy; Tamer Güneş | Zendy; Mehmet Öztürk | Zendy; Selim Kurtoğlu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Study of the Relationship Between Cystatin C and Metabolic Bone Disease in Preterm Infants

Author(s) -

Sabriye Korkut,

Şeyma Memur,

Hülya Halis,

Osman Baştuğ,

Levent Korkmaz,

Ahmet Özdemir,

Tamer Güneş,

Mehmet Öztürk,

Selim Kurtoğlu

Publication year - 2017

Publication title -

journal of clinical research in pediatric endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.566

H-Index - 35

eISSN - 1308-5735

pISSN - 1308-5727

DOI - 10.4274/jcrpe.2088

Subject(s) - medicine , cystatin c , osteopenia , gestational age , alkaline phosphatase , neonatology , metabolic bone disease , gestation , gastroenterology , kidney disease , endocrinology , pediatrics , urology , creatinine , pregnancy , bone mineral , osteoporosis , biochemistry , chemistry , biology , genetics , enzyme

Cystatin C (CysC) is commonly used as a marker of renal failure in premature infants. The aim of this study was to investigate serum CysC levels in osteopenia of prematurity (OP) and determine whether CysC could be safely used as a marker of renal insufficiency in infants with OP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research